av/interpace-biosciendl-01--big.svg

COM:INTERPACE

Interpace Biosciences

  • Stock

Last Close

2.59

22/11 20:52

Market Cap

4.86M

Beta: -

Volume Today

4.65K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
46K
-
2.78M
-
2.78M
0.25%
140K
94.97%
748K
434.29%
1.53M
104.21%
1.94M
26.91%
1.92M
1.01%
1.50M
21.57%
average payables
2.87M
-
3.33M
16.03%
2.93M
11.87%
1.94M
33.78%
1.36M
30.08%
725K
46.63%
2.94M
304.90%
4.66M
58.80%
3.60M
22.72%
1.87M
48.04%
average receivables
11.52M
-
12.41M
7.73%
9.14M
26.38%
3.19M
65.05%
2.99M
6.53%
6.46M
116.38%
9.84M
52.32%
9.11M
7.39%
7.09M
22.16%
5.59M
21.12%
book value per share
22.07
-
135.04
511.93%
84.22
37.63%
35.96
57.30%
25.35
29.51%
11.70
53.86%
3.48
70.27%
-7.22
307.59%
-10.26
42.11%
-14.88
45.08%
capex per share
-1.24
-
-76.18
6,067.00%
-2.28
97.01%
-0.02
-
-0.16
766.84%
-0.03
78.07%
-0.39
1,017.84%
-0.09
78.10%
-0.08
11.25%
capex to depreciation
-1.28
-
-4.75
272.11%
-0.07
98.52%
-0.01
-
-0.13
1,549.29%
-0.03
75.86%
-0.29
815.10%
-0.07
76.99%
-0.13
90.95%
capex to operating cash flow
0.52
-
0.69
33.89%
0.02
97.43%
0.00
-
0.05
2,624.70%
0.01
86.65%
0.11
1,463.33%
0.04
62.42%
0.04
3.11%
capex to revenue
-0.01
-
-0.09
685.27%
-0.04
60.46%
-0.00
-
-0.02
1,024.08%
-0.01
73.47%
-0.05
793.57%
-0.01
82.37%
-0.01
18.03%
cash per share
31.08
-
155.82
401.35%
54.37
65.11%
3.31
93.90%
9.64
190.81%
2.15
77.65%
0.62
71.25%
0.69
11.04%
0.80
16.49%
1.14
42.14%
days of inventory on hand
293.37
-
0.77
99.74%
13.20
1,614.85%
44.03
233.67%
41.93
4.77%
34.56
17.57%
27.90
19.28%
32.83
17.70%
days payables outstanding
6.78
-
15.51
128.59%
82.40
431.35%
127.84
55.14%
19.40
84.83%
37.91
95.44%
110.55
191.63%
75.97
31.28%
42.08
44.61%
28.17
33.06%
days sales outstanding
25.18
-
43.89
74.35%
149.14
239.78%
70.68
52.61%
78.91
11.64%
158.08
100.32%
154.57
2.22%
90.44
41.49%
54.40
39.85%
57.69
6.04%
debt to assets
0.40
-
0.12
69.32%
0.19
52.64%
0.10
-
0.10
1.06%
0.36
243.70%
1.01
182.13%
debt to equity
2.33
-
0.64
72.34%
1.21
88.01%
0.54
-
-0.16
129.94%
-0.32
98.23%
-0.26
21.10%
dividend yield
earnings yield
-0.01
-
-0.60
9,245.05%
-1.58
161.80%
-1.04
33.90%
-0.76
27.15%
-0.54
28.77%
-1.42
162.87%
-2.07
45.62%
-0.48
76.95%
-1.33
178.74%
0.17
112.79%
enterprise value
662.30M
-
30.72M
95.36%
7.29M
76.28%
15.30M
109.97%
882.32K
94.23%
16.46M
1,765.54%
23.50M
42.80%
14.62M
37.79%
41.29M
182.37%
15.67M
62.05%
enterprise value over ebitda
-232.22
-
-3.39
98.54%
-0.28
91.71%
-1.37
387.97%
-0.08
94.03%
-2.32
2,737.03%
-1.17
49.65%
-0.68
42.22%
-5.05
646.36%
-4.14
17.87%
ev to operating cash flow
-188.58
-
-1.88
99.01%
-0.37
80.42%
-1.71
366.01%
-0.06
96.62%
-1.90
3,183.03%
-1.24
34.67%
-1.00
19.11%
-4.74
372.14%
-2.04
56.98%
ev to sales
4.39
-
0.26
94.17%
0.77
201.59%
1.17
51.35%
0.06
95.25%
0.75
1,254.42%
0.98
29.85%
0.45
53.76%
1.00
121.43%
0.49
50.75%
free cash flow per share
-3.62
-
-186.09
5,038.55%
-130.46
29.89%
-49.23
62.26%
-9.70
80.30%
-3.24
66.60%
-5.10
57.30%
-4.01
21.32%
-2.19
45.27%
-1.89
13.82%
0.87
145.91%
free cash flow yield
-0.01
-
-1.04
13,708.05%
-2.81
169.87%
-1.12
60.12%
-0.95
15.01%
-0.40
57.42%
-1.02
151.68%
-1.28
25.29%
-0.29
77.00%
-1.82
519.01%
0.80
144.21%
graham net net
11.52
-
-414.39
3,696.13%
-262.21
36.72%
-180.27
31.25%
2.72
101.51%
-0.61
122.35%
-12.05
1,886.02%
-16.12
33.76%
-17.42
8.05%
-16.48
5.39%
graham number
39.24
-
572.48
1,358.80%
372.85
34.87%
192.68
48.32%
66.48
65.50%
33.75
49.23%
23.59
30.11%
32.50
37.78%
28.69
11.72%
21.53
24.97%
income quality
0.77
-
1.02
32.45%
0.60
40.97%
1.07
78.40%
1.25
16.45%
0.71
43.05%
0.71
0.32%
0.55
22.29%
0.58
5.86%
0.35
39.96%
3.41
872.69%
intangibles to total assets
0.04
-
0.54
1,384.32%
0.64
18.45%
0.87
35.49%
0.62
29.03%
0.62
0.23%
0.61
1.46%
0.43
28.68%
0.41
5.54%
0.05
86.83%
0
100%
interest coverage
-22.38
-
-10.91
51.26%
-3.00
72.45%
-14.53
383.70%
-36.61
151.92%
-54.39
48.56%
-48.37
11.07%
-12.76
73.62%
-3.81
70.14%
2.79
173.20%
interest debt per share
318.46
-
78.18
75.45%
55.35
29.20%
0.27
99.50%
0.12
57.20%
2.01
1,611.50%
1.31
34.70%
3.54
169.43%
4.03
13.99%
inventory turnover
1.24
-
474.36
38,027.06%
27.66
94.17%
8.29
70.03%
8.71
5.01%
10.56
21.32%
13.08
23.88%
11.12
15.04%
invested capital
2.33
-
0.64
72.34%
1.21
88.01%
0.54
-
-0.16
129.94%
-0.32
98.23%
-0.26
21.10%
market cap
707.94M
-
26.67M
96.23%
7.20M
73.01%
7.99M
11.01%
16.08M
101.26%
22.53M
40.09%
18.73M
16.86%
12.65M
32.46%
30.89M
144.16%
4.41M
85.73%
4.71M
6.93%
net current asset value
26.12M
-
-50.92M
294.91%
-35.51M
30.26%
-31.01M
12.68%
6.18M
119.93%
2.22M
64.12%
-39.66M
1,888.72%
-60.64M
52.92%
-68.68M
13.25%
-66.90M
2.59%
net debt to ebitda
16.00
-
-0.45
102.79%
-0.00
99.25%
-0.65
19,416.84%
1.41
315.47%
0.86
39.29%
-0.24
127.75%
-0.09
61.65%
-1.27
1,294.27%
-2.98
134.31%
net income per share
-3.10
-
-107.87
3,377.68%
-73.36
31.99%
-45.88
37.46%
-7.75
83.11%
-4.33
44.14%
-7.11
64.29%
-6.50
8.55%
-3.57
45.16%
-1.38
61.19%
0.18
113.28%
operating cash flow per share
-2.39
-
-109.91
4,506.17%
-128.18
16.62%
-49.23
61.59%
-9.68
80.33%
-3.08
68.19%
-5.06
64.31%
-3.62
28.50%
-2.11
41.73%
-1.82
13.92%
0.87
147.84%
payables turnover
53.80
-
23.54
56.25%
4.43
81.18%
2.86
35.54%
18.82
559.11%
9.63
48.83%
3.30
65.71%
4.80
45.51%
8.67
80.55%
12.96
49.39%
receivables turnover
14.50
-
8.32
42.65%
2.45
70.57%
5.16
111.00%
4.63
10.43%
2.31
50.08%
2.36
2.27%
4.04
70.90%
6.71
66.24%
6.33
5.69%
research and ddevelopement to revenue
0.24
-
0.13
48.20%
0.09
26.98%
0.10
5.55%
0.12
20.30%
0.09
26.07%
0.05
47.20%
0.02
51.53%
0.02
28.37%
return on tangible assets
-0.07
-
-0.30
341.57%
-0.47
54.77%
-1.54
227.87%
-0.60
61.22%
-0.66
10.00%
-0.98
49.82%
-1.01
2.99%
-0.65
35.81%
-0.39
40.26%
revenue per share
102.49
-
804.88
685.34%
60.93
92.43%
72.05
18.26%
10.08
86.01%
7.78
22.89%
6.43
17.33%
8.04
25.10%
9.99
24.25%
7.51
24.81%
9.21
22.66%
roe
-0.14
-
-0.80
468.31%
-0.87
9.04%
-1.28
46.47%
-0.31
76.04%
-0.37
21.08%
-2.05
452.63%
0.90
144.05%
0.35
61.41%
0.09
73.25%
roic
-0.14
-
-0.13
2.49%
-1.32
890.77%
-0.44
66.96%
-0.15
65.11%
-0.37
141.29%
-0.99
167.91%
1.36
237.56%
0.46
66.15%
0.09
81.16%
sales general and administrative to revenue
0.19
-
0.24
27.81%
1.79
638.12%
0.80
55.26%
0.58
28.28%
0.39
32.59%
0.60
55.63%
0.64
6.12%
0.33
48.39%
0.34
4.17%
shareholders equity per share
22.07
-
135.04
511.93%
84.22
37.63%
35.96
57.30%
25.35
29.51%
11.70
53.86%
3.48
70.27%
-7.22
307.59%
-10.26
42.11%
-14.88
45.08%
stock based compensation to revenue
0.01
-
0.02
55.04%
0.43
2,304.86%
0.01
97.65%
0.08
701.75%
0.10
29.16%
0.06
38.51%
0.07
5.89%
0.03
50.95%
0.04
23.69%
tangible asset value
29.96M
-
-42.73M
242.63%
-30.45M
28.72%
-29.83M
2.06%
6.86M
123.01%
3.08M
55.06%
-28.91M
1,037.05%
-48.87M
69.04%
-58.14M
18.97%
-63.93M
9.97%
tangible book value per share
20.35
-
-286.74
1,508.81%
-196.73
31.39%
-164.25
16.51%
4.35
102.65%
1.10
74.84%
-7.72
804.41%
-12.13
57.17%
-14.06
15.92%
-15.09
7.30%
working capital
31.31M
-
11.29M
63.95%
-4.21M
137.28%
-12.00M
185.19%
11.82M
198.47%
9.23M
21.90%
-929K
110.07%
-4.11M
342.52%
-3.52M
14.47%
-2.13M
39.45%

All numbers in (except ratios and percentages)